Targeting Complement C5a Receptor 1 for the Treatment of Immunosuppression in Sepsis.
Sommerfeld O, Medyukhina A, Neugebauer S, Ghait M, Ulferts S, Lupp A, König R, Wetzker R, Schulz S, Figge MT, Bauer M, Press AT.
Sommerfeld O, et al. Among authors: lupp a.
Mol Ther. 2021 Jan 6;29(1):338-346. doi: 10.1016/j.ymthe.2020.09.008. Epub 2020 Sep 5.
Mol Ther. 2021.
PMID: 32966769
Free PMC article.